Avelumab in combination with axitinib (Ave + Axi) for first-line (1L) treatment of advanced renal cell carcinoma (aRCC): A systematic literature review (SLR) of real-world effectiveness and safety.
Year: 2025
Type: conference-abstract
Study design: Systematic Review
Source: Journal of Clinical Oncology
Authors: Mairead Kearney, Ankush Taneja, Aniket Sharma, Ahmed Elsada, Anna-Maria Fontrier, Stamatia Alexopoulos, Neil Roskell
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407698933